InsiderDB

Insulet (PODD)

Healthcare · Medical - Devices

5 members of Congress have disclosed 21 trades in Insulet (PODD) since 2018: 5 buys and 16 sales. The most recent was disclosed on Oct 12, 2026.

Trades disclosed
21
Members trading
5
Buys / sells
5 / 16
Reported value
$978K–$2.3M

Keep following the company.

Subscribers get new congressional filings and notable insider purchases for companies they follow. Coverage varies by company.

Follow PODD

Research connections

Patterns in the available disclosures. Each source has its own timing and reporting limits.

What else is happening at PODD

All research →

Company filings and public records connected to this stock, ordered by when they became public or were first observed.

  1. PODDFinancial report·SEC EDGAR

    PODD: 10-Q financial filing

    Filed 10-Q for an event or period dated 2026-09-30. Read the company report for its disclosures.

    Public: Nov 4, 2026, 4:05 PM ESTEvent / period: Sep 30, 2026Original source ↗

    2 congressional households disclosed purchases in the past 90 days. See the trades

  2. PODDCompany announcement·SEC EDGAR

    PODD: Financial results · Company disclosure

    Filed 8-K for an event or period dated 2026-11-04. Financial results; Company disclosure.

    Public: Nov 4, 2026, 7:01 AM ESTEvent / period: Nov 4, 2026Original source ↗

    2 congressional households disclosed purchases in the past 90 days. See the trades

  3. PODDLobbying report·Lobbying disclosures

    PODD: fourth_quarter 2026 lobbying report

    General education on diabetes care. General education about Insulet

    Public: Nov 3, 2026, 1:07 PM ESTOriginal source ↗

    2 congressional households disclosed purchases in the past 90 days. See the trades

  4. PODDLobbying report·Lobbying disclosures

    PODD: third_quarter 2026 lobbying report

    Issues related to the disease of diabetes, diabetes therapies, automated insulin delivery devices, and management of the disease of diabetes. Issues related to medical devices and medical device technologies. Issues related to Pharmacy Benefit Manager (PBM) reform proposals, PBM transparency and potential PBM proposals related to talks of future budget reconciliation and/or year end package. Issues related to the DIABETES Act. Issues related to artificial intelligence (AI) and predictive algorithms in medical devices and medical device technology. Issues related to tariffs and trade and the Se

    Public: Oct 20, 2026, 9:26 AM EDTOriginal source ↗

    2 congressional households disclosed purchases in the past 90 days. See the trades

  5. PODDLobbying report·Lobbying disclosures

    PODD: third_quarter 2026 lobbying report

    General education on diabetes care. General education about Insulet.

    Public: Oct 19, 2026, 9:56 AM EDTOriginal source ↗

    2 congressional households disclosed purchases in the past 90 days. See the trades

Who traded PODD

All trades

1 new trade of PODD in the last 24 hours. Members got it by email.

From periodic transaction reports filed under the STOCK Act. Amounts are the ranges members report, and trades can be disclosed up to 45 days after they happen. Nothing here is investment advice.